Edeker B L, Rasmussen G T, Britigan B E
Research Service, VA Medical Center, Iowa City, Iowa, USA.
J Leukoc Biol. 1995 Jul;58(1):59-64. doi: 10.1002/jlb.58.1.59.
Exposure to hypochlorous acid (HOCl), the main product of the reaction of neutrophil myeloperoxidase (MPO), H2O2, and Cl-, reportedly decreases apotransferrin's iron binding capacity. Optimal transferrin iron binding requires the coexistent binding of anions such as bicarbonate (HCO3-) near the protein's two iron binding sites. Recently, we found that if HCO3- was also present during HOCl exposure, apotransferrin retained its ability to inhibit iron-catalyzed hydroxyl radical generation. Therefore, we examined apotransferrin iron binding capacity after exposure to the MPO/H2O2/I- system in the presence and absence of several anions (HCO3-, H2PO4, SO4(2-), and ClO4-) known to bind to apotransferrin. Although the MPO system decreased apotransferrin iron uptake to only 46% of the untreated apotransferrin control, apotransferrin treated in the presence of 1 mM HCO3- or H2PO4- retained 84 and 74%, respectively, of its iron binding capacity. Similar results were seen when apotransferrin was treated with NaOCl. These results could not be explained on the basis of a loss of MPO activity or scavenging of HOCl. In contrast, SO4(2-) and ClO4- were unable to prevent the MPO-mediated loss of apotransferrin iron binding capacity. NaOCl had no effect on the ability of transferrin to bind any of these anions, as assessed by the anion-induced change in apotransferrin absorbance spectrum. HCO3- but not H2PO4-, SO4(2-), or ClO4- decreased MPO-mediated oxidation (iodination) of apotransferrin. Under some conditions H2PO4- actually increased apotransferrin iodination. HCO3- and H2PO4- may protect apotransferrin from MPO-mediated oxidative damage by preventing selective oxidation of one or both iron binding sites. This process may allow transferrin to retain its iron binding function during MPO exposure in vivo.
据报道,暴露于次氯酸(HOCl)——中性粒细胞髓过氧化物酶(MPO)、H2O2和Cl-反应的主要产物——会降低脱铁转铁蛋白的铁结合能力。转铁蛋白与铁的最佳结合需要在蛋白质的两个铁结合位点附近同时存在阴离子,如碳酸氢根(HCO3-)。最近,我们发现,如果在暴露于HOCl的过程中也存在HCO3-,脱铁转铁蛋白仍保留其抑制铁催化产生羟基自由基的能力。因此,我们检测了在存在和不存在几种已知可与脱铁转铁蛋白结合的阴离子(HCO3-、H2PO4-、SO4(2-)和ClO4-)的情况下,脱铁转铁蛋白在暴露于MPO/H2O2/I-体系后的铁结合能力。尽管MPO体系使脱铁转铁蛋白的铁摄取量仅降至未处理的脱铁转铁蛋白对照的46%,但在1 mM HCO3-或H2PO4-存在下处理的脱铁转铁蛋白分别保留了其铁结合能力的84%和74%。用NaOCl处理脱铁转铁蛋白时也观察到了类似结果。这些结果无法用MPO活性丧失或HOCl清除来解释。相反,SO4(2-)和ClO4-无法阻止MPO介导的脱铁转铁蛋白铁结合能力的丧失。通过脱铁转铁蛋白吸收光谱中阴离子诱导的变化评估,NaOCl对转铁蛋白结合这些阴离子的能力没有影响。HCO3-而非H2PO4-、SO4(2-)或ClO4-可降低MPO介导的脱铁转铁蛋白氧化(碘化)。在某些条件下,H2PO4-实际上会增加脱铁转铁蛋白的碘化。HCO3-和H2PO4-可能通过防止一个或两个铁结合位点的选择性氧化来保护脱铁转铁蛋白免受MPO介导的氧化损伤。这一过程可能使转铁蛋白在体内暴露于MPO期间保留其铁结合功能。